NYMOX PHARMACEUTICAL CORP's ticker is and the CUSIP is P73398952. A total of 2 filers reported holding NYMOX PHARMACEUTICAL CORP in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $950 | -65.9% | 5,000 | -39.0% | 0.00% | – |
| Q1 2023 | $2,788 | +14.5% | 8,200 | 0.0% | 0.00% | – |
| Q4 2022 | $2,435 | -39.1% | 8,200 | -19.6% | 0.00% | – |
| Q3 2022 | $4,000 | 0.0% | 10,200 | 0.0% | 0.00% | – |
| Q2 2022 | $4,000 | -55.6% | 10,200 | +39.7% | 0.00% | – |
| Q1 2022 | $9,000 | 0.0% | 7,300 | 0.0% | 0.00% | – |
| Q4 2021 | $9,000 | -65.4% | 7,300 | -42.5% | 0.00% | – |
| Q3 2021 | $26,000 | +225.0% | 12,700 | +154.0% | 0.00% | – |
| Q2 2021 | $8,000 | +100.0% | 5,000 | +233.3% | 0.00% | – |
| Q4 2020 | $4,000 | -33.3% | 1,500 | -40.0% | 0.00% | – |
| Q3 2020 | $6,000 | +200.0% | 2,500 | +400.0% | 0.00% | – |
| Q2 2020 | $2,000 | -66.7% | 500 | -80.0% | 0.00% | – |
| Q1 2020 | $6,000 | 0.0% | 2,500 | 0.0% | 0.00% | – |
| Q4 2019 | $6,000 | -92.2% | 2,500 | -95.7% | 0.00% | -100.0% |
| Q4 2018 | $77,000 | -52.8% | 58,400 | -12.0% | 0.00% | 0.0% |
| Q3 2018 | $163,000 | -30.3% | 66,400 | -4.6% | 0.00% | -50.0% |
| Q2 2018 | $234,000 | -49.5% | 69,600 | -36.4% | 0.00% | -60.0% |
| Q1 2018 | $463,000 | +120.5% | 109,500 | +71.9% | 0.01% | +400.0% |
| Q4 2017 | $210,000 | -76.2% | 63,700 | -72.5% | 0.00% | -87.5% |
| Q3 2017 | $884,000 | -19.9% | 231,300 | -7.8% | 0.01% | -27.3% |
| Q2 2017 | $1,104,000 | -15.1% | 250,900 | -30.0% | 0.01% | -26.7% |
| Q1 2017 | $1,301,000 | +262.4% | 358,400 | +166.7% | 0.02% | +400.0% |
| Q4 2016 | $359,000 | +7.2% | 134,400 | +30.7% | 0.00% | -25.0% |
| Q3 2016 | $335,000 | +365.3% | 102,800 | +367.3% | 0.00% | +300.0% |
| Q4 2015 | $72,000 | – | 22,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|